Partnership to End Addiction expands esteemed Board of Directors
"We are honored to welcome these talented individuals who bring tremendous professional expertise and personal passion to our mission of ending the addiction crisis," said
The new members join Partnership to End Addiction's impressive Board, providing governance and guidance to the national nonprofit's efforts to solve the addiction crisis by equipping families with reliable, actionable resources.
View the full Board of Directors.
About Partnership to End Addiction
Partnership to End Addiction is a national nonprofit empowering families impacted by the devastating addiction crisis. With personalized support, evidence-based resources, and decades of expertise, we provide families with the tools to prevent substance use disorders and guide their loved ones into treatment and long-term recovery. As the most significant influence on youth substance use, families are vital to ending this crisis. Join our mission to destigmatize addiction, increase access to care, and mobilize families as partners in creating a comprehensive support ecosystem that saves lives. Visit drugfree.org to learn more and help create change for communities nationwide.
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/partnership-to-end-addiction-expands-esteemed-board-of-directors-302181864.html
SOURCE Partnership to End Addiction
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clarivoy Unveils the Next Generation of Its Independent Attribution Platform, Featuring Claire, an AI Data Analyst Built for Automotive Retail
- Greenberg Traurig's Ian Marx Wins 'Pro Bono Lawyer of the Year' at 2026 New Jersey Legal Awards
- Cloud Software Group Announces Amendment of Offer to Purchase for Cash up to $2.0 Billion Aggregate Principal Amount of its 9.00% Senior Secured Second Lien Notes due 2029
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
JPMorgan, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share